Next-generation cell and gene therapies now.
In today’s advanced therapies market, progress depends on making the right decisions early — before capital is committed and timelines are locked.
Whether you’re evaluating modalities, assessing manufacturing strategies, or pressure-testing costs and schedules, success begins with clear, grounded plans that align with your science and your business case.
CRB partners with advanced therapy innovators to move programs forward with confidence, starting where the industry is today.
Our services include:
- Facility test fits and manufacturing option analysis
- Flexible layout development and space planning
- Dynamic simulation, operational modeling, and debottlenecking
- Biocontainment, isolation strategies, and ATMP safety systems
- IV bag and custom fill-finish equipment integration
- GMP design reviews, gap assessments, and inspection readiness
- Value engineering, cost optimization, and FDA pre-construction support
Expert Perspectives on Cell and Gene Therapy
Advanced Therapies in Action
See how CRB supports cell & gene therapy programs across the lifecycle—from early concept through commercial readiness.
What We're Seeing in Cell and Gene Therapy Manufacturing

Peter Walters
Fellow, Advanced Therapies
Connect with Our Team
Learn more about how CRB helps our clients evaluate options, reduce risk, and build operationally sound paths to market.
Let’s optimize your process, together.
.jpg?width=2000&height=1500&name=Horizons%20LS25%20Report%20Spreads%20Mockup%20(TEST).jpg)






